MedTrace Logo

Botox for Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)

NCT00529386 · Status: TERMINATED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 7

Last updated 2019-03-25

Study results available
· View outcomes & findings →

Summary

The objective of this study is to evaluate the safety and efficacy of intraprostatic injection of Botox for the treatment of men diagnosed with chronic nonbacterial prostatitis/chronic pelvic pain syndrome (CP/CPPS).

Conditions

  • Prostatitis
  • Chronic Pain Syndrome

Interventions

DRUG

Botox

300 units

Sponsors & Collaborators

  • Allergan

    collaborator INDUSTRY

  • Queen's University

    lead OTHER

Principal Investigators

  • J. Curtis Nickel, MD FRCSC · Queen's University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-01-31
Primary Completion
2009-09-30
Completion
2009-12-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00529386 on ClinicalTrials.gov